This is a real case reported in the "Light of Technology" column of CCTV's science and technology channel. After receiving treatment with tumor cell targeted immune technology for a period of time, lung cancer patients have been effectively controlled.

According to the staff of Hainan Yishi Kangning Biotechnology Co., Ltd., who has just settled in Haikou, the tumor cell targeted immune technology is to separate monocytes and T lymphocytes from the peripheral blood of patients, and then culture them into DC cells and targeted cells. Toxic T lymphocytes, use these cells to kill related cancer cells, destroy tumor angiogenesis, and ultimately achieve the purpose of treating tumors.

Through investigation and comparison, Hainan Yishi Kangning Biotechnology Co., Ltd. chose to enter the Haikou National High-tech Zone Entrepreneurship Incubation Center, and will specialize in research and development of tumor cell-targeted immune technology.

Cai Qiuyu, a staff member of Hainan Yishikangning Biotechnology Co., Ltd. said: “Hainan’s ecological environment and the concept of a healthy island will attract more and more people to seek high-end medical services. We hope that our technology can match all aspects of Hainan. The combination of its policy advantages can help Hainan’s overall improvement of international medical standards."